Abstract
Venous Thromboembolism Risk in Patients with Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination with Lenalidomide and Dexamethasone
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have